Related Experiment Video
Updated: Jul 4, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
AMPK, a key molecule regulating aging-related myocardial ischemia-reperfusion injury
Xiaorui Yin1, Ziyuan Guo1, Chunli Song2
1Department of Cardiology, Second Hospital of Jilin University, No.218 Ziqiang Street, Changchun, 130041, China.
Abstract:
Aging leads to the threat of more diseases to the biological anatomical structure and the decline of disease resistance, increasing the incidence and mortality of myocardial ischemia-reperfusion injury (MI/RI). Moreover, MI/RI promotes damage to an aging heart. Notably, 5'-adenosine monophosphate-activated protein kinase (AMPK) regulates cellular energy metabolism, stress response, and protein metabolism, participates in aging-related signaling pathways, and plays an essential role in ischemia-reperfusion (I/R) injury diseases. This study aims to introduce the aging theory, summarize the interaction between aging and MI/RI, and describe the crosstalk of AMPK in aging and MI/RI. We show how AMPK can offer protective effects against age-related stressors, lifestyle factors such as alcohol consumption and smoking, and hypertension. We also review some of the clinical prospects for the development of interventions that harness the effect of AMPK to treat MI/RI and other age-related cardiovascular diseases.
Insights
Aging increases myocardial ischemia-reperfusion injury (MI/RI) risk. This study explores how 5'-adenosine monophosphate-activated protein kinase (AMPK) protects against age-related heart damage and disease, offering potential therapeutic strategies.
Area of Science:
- Cardiovascular Biology
- Aging Research
- Metabolic Regulation
Background:
- Aging compromises the heart's resilience, elevating susceptibility to myocardial ischemia-reperfusion injury (MI/RI).
- Aging is linked to increased incidence and mortality from MI/RI, exacerbating cardiac damage.
- 5 -adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of cellular metabolism and stress responses, implicated in aging and I/R injury.
Purpose of the Study:
- To elucidate the interplay between aging and MI/RI.
- To detail the role and mechanisms of AMPK in aging and MI/RI.
- To explore AMPK-targeted interventions for age-related cardiovascular conditions.
Main Methods:
- Review of aging theories and their impact on cardiovascular health.
- Analysis of the literature on AMPK's function in cellular energy and stress pathways.
- Synthesis of research on AMPK's protective effects in the context of aging and I/R.
Main Results:
- AMPK activation demonstrates protective effects against age-associated cardiac stressors.
- AMPK signaling is crucial in mitigating damage from lifestyle factors (alcohol, smoking) and hypertension.
- AMPK plays a significant role in managing cellular energy homeostasis during ischemic events.
Conclusions:
- AMPK emerges as a critical mediator in combating age-related cardiovascular decline and MI/RI.
- Targeting AMPK pathways presents promising therapeutic avenues for treating MI/RI and other age-associated heart diseases.
- Understanding AMPK's multifaceted role is vital for developing effective interventions in geriatric cardiology.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...